Markers | LumWalA | Luminal B, HER2- | Luminal B, HER2+ | HER2 | Basal-hke | Total |
---|---|---|---|---|---|---|
No. of tumors | 111 (30.6%) | 95 (26.2%) | 69 (19.0%) | 41 (11.3%) | 47 (12.9%) | 363 |
Age (range) | 58.6 (34ā84) | 54.8 (27ā84) | 54.7 (30ā78) | 58,9 (38ā87) | 56.8 (31ā84) | 56.7 |
Ki-67c14% | 111 (100%) | 0 (0%) | 10 (14.5%) | 1 (24.3%) | 4 (8.5%) | 126 (34.7%) |
K6714% | 0 (0%) | 95 (100%) | 59 (85.5%) | 40 (97.8%) | 43 (91.5%) | 237 (65.3%) |
DiploEd | 78 (70.3%) | 44 (46.3%) | 11 (15.9%) | 3 (7.3%) | 8 (17.0%) | 140 (38.6%) |
Aneuploid | 33 (29.7%) | 51 (53.7%) | 58 (84.1%) | 38 (92.7%) | 39 (83.0%) | 223 (61.4%) |
CIN- | 74 (66.7%) | 43 (45.3%) | 10 (14.5%) | 3 (7.3%) | 10 (21.3%) | 140 (38.6%) |
CIN. | 37 (33.3%) | 52 (54.7%) | 59 (85.5%) | 38 (92.7%) | 37 (787%) | 223 (61.4%) |
DipIod!ClN- | 72 (64.9) | 39 (41.1%) | 8 (11.6%) | 2 (4.9%) | 8 (17.0%) | 129 (35.5%) |
AneuplodiClN+ | 31 (27.9%) | 47 (49.5%) | 56 (81.2%) | 372 (90.2%) | 36 (76.6%) | 207 (57.0%) |
Grade 1 | 53 (47.7%) | 15 (15.8%) | 6 (8.7%) | 0 (0%) | 4 (8.5%) | 78 (20.4%) |
Grade 2 | 32 (28.8%) | 23 (24.2%) | 10 (14.5%) | 2 (4.9%) | 2 (4.3%) | 69 (19.0%) |
Grade 3 | 20 (18.0%) | 56 (58.9%) | 52 (58.9%) | 38 (92.7%) | 40 (85.1%) | 206 (57.3%) |
nd | 6 | 1 | 1 | 1 | 1 | 10 |